Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.36B | 8.58B | 8.56B | 8.56B | 8.29B | 7.98B |
Gross Profit | 2.29B | 2.29B | 2.17B | 2.24B | 2.04B | 1.93B |
EBITDA | 408.61M | 525.06M | 386.12M | 415.83M | 288.23M | 164.93M |
Net Income | 228.87M | 302.54M | 195.24M | 214.12M | 139.64M | 39.00M |
Balance Sheet | ||||||
Total Assets | 7.65B | 7.33B | 6.94B | 6.90B | 6.64B | 5.99B |
Cash, Cash Equivalents and Short-Term Investments | 1.35B | 1.19B | 1.13B | 1.28B | 927.96M | 187.05M |
Total Debt | 1.15B | 987.35M | 1.01B | 1.05B | 1.10B | 1.03B |
Total Liabilities | 3.39B | 3.31B | 3.44B | 3.58B | 3.43B | 3.11B |
Stockholders Equity | 4.26B | 4.02B | 3.50B | 3.32B | 3.21B | 2.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -58.74M | -37.86M | 431.16M | 30.24M | 46.00M |
Operating Cash Flow | 0.00 | 27.18M | 42.74M | 496.33M | 191.92M | 144.00M |
Investing Cash Flow | 0.00 | 90.86M | -97.84M | -52.04M | -152.24M | -73.00M |
Financing Cash Flow | 0.00 | -56.30M | -96.57M | -88.35M | 42.92M | 4.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥6.14B | 9.39 | 3.13% | 6.58% | 29.17% | ||
77 Outperform | ¥7.36B | 10.12 | 1.48% | -12.80% | -64.72% | ||
69 Neutral | ¥1.52B | 6.69 | 3.15% | -1.56% | -24.77% | ||
67 Neutral | £2.80B | 13.41 | 4.69% | 3.43% | 2.35% | -24.51% | |
65 Neutral | ¥1.93B | 13.69 | 3.05% | 0.89% | 6.55% | ||
63 Neutral | ¥2.39B | 29.86 | 2.43% | -3.66% | -72.39% | ||
56 Neutral | ¥2.56B | 6.03 | 5.59% | 2.38% | ― |